Page last updated: 2024-10-23

aztreonam and Hemorrhagic Shock

aztreonam has been researched along with Hemorrhagic Shock in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Research Excerpts

ExcerptRelevanceReference
"To describe the pharmacokinetic profile of aztreonam and vancomycin hydrochloride in a clinically relevant experimental model of hemorrhagic shock and trauma."3.69Antibiotic pharmacokinetics following fluid resuscitation from traumatic shock. ( Boucher, BA; Croce, MA; Fabian, TC; McKindley, DS; Proctor, KG, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McKindley, DS1
Fabian, TC1
Boucher, BA1
Croce, MA1
Proctor, KG1

Other Studies

1 other study available for aztreonam and Hemorrhagic Shock

ArticleYear
Antibiotic pharmacokinetics following fluid resuscitation from traumatic shock.
    Archives of surgery (Chicago, Ill. : 1960), 1995, Volume: 130, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Aztreonam; Disease Models, Animal; Female; Fluid Therapy; Hemodynami

1995